View all Webinars

Schwegman Lundberg & Woessner

Close     Close Mobile Menu

Categories

Recent

Destination IP Virtual Summit Offers an Online Journey
This August, the Destination IP Virtual Summit offers a way...
Stay Connected with a Summer of Complimentary Webinars
This summer, the SLW Institute is providing a wide range...
We Stand with You
As a firm founded in Minneapolis with colleagues spread throughout...
Lea Westman Leads St. Thomas IP Moot Court to National Competition
Zoom has helped meetings and family events continue during the...
International Patent Office Contact Information and Updates on COVID-19
To help you navigate these challenging times, we have assembled...
Three New Webinars Discuss Current (and Global) Issues
In March and early April, three new SLW Institute webinars...

Warren Woessner to Speak at Bio IP & Diagnostics Symposium

Warren Woessner, founding shareholder of Schwegman, will be speaking at the Bio IP & Diagnostics Symposium (Bio IPDx) on September 19, 2017, in Alexandria, VA.

Dr. Woessner will be speaking alongside Dr. Leslie Fischer of Novartis and Hans Sauer of Biotechnology Innovation Organization in a panel-style discussion titled “The Walls Are Closing In – The Bleak Future of Claims Reciting Natural ‘Correlations’ and Products of Nature.”  The three will discuss how recent developments regarding section 101 may once again increase patentability in this technology space.

Warren’s practice focuses on chemical patent law, including biotechnology, pharmaceuticals, vaccines, medical treatments, diagnostics, and biofuels and agricultural chemistry, including related opinion and licensing matters. In addition, he has served as an expert witness and also works in mediation of inventorship disputes and solutions for complex prosecution problems.

This seminar will be held at the Westin Alexandria from 7:30 am – 2:15 pm.

 

  Back to All News